These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 10445388
1. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies. Daniel WA, Syrek M, Haduch A, Wójcikowski J. Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388 [Abstract] [Full Text] [Related]
2. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat. Daniel WA, Syrek M, Haduch A, Wójcikowski J. J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361 [Abstract] [Full Text] [Related]
5. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies. Daniel WA, Syrek M, Haduch A. Pol J Pharmacol; 1999 Apr; 51(5):435-42. PubMed ID: 10817545 [Abstract] [Full Text] [Related]
6. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. Ball SE, Ahern D, Scatina J, Kao J. Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822 [Abstract] [Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Baumann P. Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657 [Abstract] [Full Text] [Related]
8. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment. Daniel WA, Syrek M, Mach A, Wójcikowski J, Boksa J. Pol J Pharmacol; 1997 Dec; 49(6):439-52. PubMed ID: 9566048 [Abstract] [Full Text] [Related]
9. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants. Daniel WA, Haduch A, Wójcikowski J. J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558 [Abstract] [Full Text] [Related]
10. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A. Haduch A, Wójcikowski J, Daniel WA. Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530 [Abstract] [Full Text] [Related]
11. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence. Sproule BA, Naranjo CA, Brenmer KE, Hassan PC. Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993 [Abstract] [Full Text] [Related]
17. Effect of short- and long-term treatment with antidepressant drugs on the activity of rat CYP2A in the liver. Haduch A, Wójcikowski J, Daniel WA. Pharmacol Rep; 2005 Sep; 57(6):774-81. PubMed ID: 16382196 [Abstract] [Full Text] [Related]
18. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin. Desta Z, Soukhova N, Flockhart DA. J Clin Psychopharmacol; 2002 Apr; 22(2):162-8. PubMed ID: 11910261 [Abstract] [Full Text] [Related]
19. The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors. Belpaire FM, Wijnant P, Temmerman A, Rasmussen BB, Brøsen K. Eur J Clin Pharmacol; 1998 May; 54(3):261-4. PubMed ID: 9681670 [Abstract] [Full Text] [Related]